KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Assets Average: 2011-2025

Historic Assets Average for TherapeuticsMD (TXMD) over the last 9 years, with Sep 2025 value amounting to $38.6 million.

  • TherapeuticsMD's Assets Average fell 3.14% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $41.1 million for FY2024, which is 38.60% down from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Assets Average is $38.6 million, which was up 0.57% from $38.4 million recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Assets Average peaked at $225.0 million during Q2 2021, and registered a low of $38.4 million during Q2 2025.
  • In the last 3 years, TherapeuticsMD's Assets Average had a median value of $41.1 million in 2024 and averaged $46.3 million.
  • In the last 5 years, TherapeuticsMD's Assets Average increased by 5.63% in 2021 and then crashed by 62.81% in 2023.
  • TherapeuticsMD's Assets Average (Quarterly) stood at $189.6 million in 2021, then tumbled by 40.82% to $112.2 million in 2022, then tumbled by 58.19% to $46.9 million in 2023, then declined by 16.45% to $39.2 million in 2024, then fell by 3.14% to $38.6 million in 2025.
  • Its Assets Average was $38.6 million in Q3 2025, compared to $38.4 million in Q2 2025 and $38.5 million in Q1 2025.